Tweeting While Psychiatry Burns

February, 27, 2017 | 2 Comments


  1. This is not quite what happens when ‘treatments work’

    ‘transforming social order’

    This is the anniversary of this article, a latter day eulogy to Tweeting While Psychiatry Burns but without addressing the ‘Delay’ – a remarkable history with pictures, Part 1.

    EXCLUSIVE: How Big Pharma greed is killing tens of thousands around the world: Patients are over-medicated and often given profitable drugs with ‘little proven benefits,’ leading doctors warn

    Queen’s former doctor, Sir Richard Thompson, has backed new campaign
    Experts calling for urgent public enquiry into drugs firms’ ‘murky’ practices
    They say too much medicine is doing more harm than good worldwide
    And claim many drugs such as statins are less effective than thought

    By Anna Hodgekiss for MailOnline and Ben Spencer Medical Correspondent For The Daily Mail
    Published: 22:00, 23 February 2016 | Updated: 11:54, 24 February 2016


    A spokesman for the Association of the British Pharmaceutical Industry said: ‘All medicines undergo rigorous testing for quality, safety and efficacy by global regulators.

    ‘The data is also subject to continuous scrutiny during trials, once licensed and throughout the life of the medicine, including after a patent has expired.’ 

    The spokesman added: ‘The assessment of a medicine – the benefits and risks it brings to patients as well as the value it provides to healthcare – is an ongoing process.

    ‘Innovating companies discover and develop new uses for these medicines over the life of these products, and regulators and health technology assessors continue to update their assessments based on new information.

    ‘None of these procedures are “weak” or “murky” but by and large published for public scrutiny.’

    ‘However, we recognise that the discussion on the evaluation of medicines is timely, and we were pleased to contribute together with many other stakeholders to the “Evaluating Evidence” policy programme of the Academy of Medical Sciences.

    ‘This dialogue is critical to achieve a shared constructive and progressive framework for the assessment of medicines.’ 

    A spokesman for NHS England last night declined to comment on the allegations. 

    we can draw a parallel from David’s Magnificent X1 to these Magnificent 11 ..

    Offload Pump

  2. B.C. firm reaches $6.2M Paxil settlement in class action against GlaxoSmithKline

    By The Canadian Press
    Wed., March 1, 2017

    GlaxoSmithKline Inc. says it has agreed in principle to settle the lawsuit but it does not admit to any liability or wrongdoing.

    Moms reach $6.2m settlement over claims that anti-depressant caused kids’ heart problems

    In an email, GlaxoSmithKline said that despite the settlement in principle, it does not admit to any liability or wrongdoing but has agreed to resolve the class action case to avoid the time and expense associated with a trial and subsequent steps in the proceedings.

    “We continue to be of the view that the scientific evidence does not establish that exposure to Paxil during pregnancy causes cardiovascular birth defects.

    “Patient safety is our highest concern and we continue to believe that the company provided accurate and updated information in relation to Paxil to regulators, and communicated important safety information to regulatory agencies, the scientific community and healthcare professionals.”

Leave a Reply